DECREASED PLASMA-PROTEIN BINDING OF VALPROATE IN PATIENTS WITH ACUTE HEAD TRAUMA

被引:30
|
作者
ANDERSON, GD
GIDAL, BE
HENDRYX, RJ
AWAN, AB
TEMKIN, NR
WILENSKY, AJ
WINN, HR
机构
[1] UNIV WASHINGTON,SCH PHARM,DEPT NEUROL SURG,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PHARM,DEPT BIOSTAT,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195
[4] UNIV WASHINGTON,SCH PUBL HLTH,SEATTLE,WA 98195
关键词
VALPROATE; PROTEIN BINDING; HYPOALBUMINEMIA; HEAD TRAUMA;
D O I
10.1111/j.1365-2125.1994.tb04304.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 One hundred and ten plasma samples were obtained from 50 patients treated with valproate for prophylaxis of post-traumatic head injuries. The samples were selected to include a wide range of albumin concentrations and were assayed for free and total valproate concentrations. Valproate binding parameters were determined from the Scatchard equation for one binding site using reweighted least squares analysis. 2 Plasma albumin concentrations were measured in 130 patients with head trauma. They started to decrease immediately after trauma, reaching a minimum at 5-7 days of approximately 24% of baseline value and did not return to normal until 1 month. 3 The free fraction of valproate varied six to seven-fold as albumin concentration ranged from 1.5 to 4.8 g 100 ml(-1) (218-696 mu mol 1(-1)). The mean association constant for binding (K-a) was 0.008 mu mol 1(-1) and the mean number of binding sites (N) was 2.0. There values were similar to those reported for valproate in otherwise healthy patients with epilepsy. 4 Because of saturable protein binding of valproate, hypoalbuminaemia may necessitate the monitoring of free valproate concentrations to avoid toxicity when valproate is used in patients with acute head injury.
引用
收藏
页码:559 / 562
页数:4
相关论文
共 50 条
  • [21] THE PLASMA-PROTEIN BINDING OF HIDA
    NICHOLSON, RW
    HERMAN, KJ
    SHIELDS, RA
    TESTA, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1980, 5 (04): : 311 - 312
  • [22] PLASMA-PROTEIN BINDING OF CEFTRIAXONE
    POPICK, AC
    CROUTHAMEL, WG
    BEKERSKY, I
    XENOBIOTICA, 1987, 17 (10) : 1139 - 1145
  • [23] PLASMA-PROTEIN BINDING OF PHENCYCLIDINE
    GILES, HG
    MILLER, RB
    KHOUW, V
    JUZYTSCH, W
    SELLERS, EM
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 318 - 318
  • [24] PLASMA-PROTEIN BINDING OF PHENYTOIN IN CRITICALLY ILL PATIENTS
    QUANDT, CM
    FREEMAN, CM
    HORST, HM
    ELIAS, SB
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06): : 438 - 438
  • [25] PLASMA-PROTEIN BINDING OF EPINEPHRINE
    RUSSELL, JC
    DOTY, DM
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 : 1414 - &
  • [26] PLASMA-PROTEIN BINDING OF BEPRIDIL
    PRITCHARD, JF
    MCKOWN, LA
    DVORCHIK, BH
    ONEILL, PJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (05): : 347 - 353
  • [27] PLASMA-PROTEIN BINDING OF TENOXICAM
    LANMAN, RC
    STOLTZ, ML
    FASEB JOURNAL, 1991, 5 (06): : A1565 - A1565
  • [28] PLASMA-PROTEIN BINDING AND KINETICS OF DIPHENYLHYDANTOIN IN UREMIC PATIENTS
    BORGA, O
    ODARCEDERLOF, I
    ACTA PHARMACEUTICA SUECICA, 1974, 11 (06): : 653 - 654
  • [29] PLASMA-PROTEIN BINDING OF PHENYTOIN IN 100 EPILEPTIC PATIENTS
    PETERSON, GM
    MCLEAN, S
    ALDOUS, S
    VONWITT, RJ
    MILLINGEN, KS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) : 298 - 300
  • [30] PLASMA-PROTEIN BINDING OF EPINEPHRINE
    RUSSELL, JC
    DOTY, DM
    PHYSIOLOGICAL CHEMISTRY AND PHYSICS, 1973, 5 (01): : 75 - 86